ClinicalTrials.gg

Program

GK01

A development code. Also written as “GK01 Injection” and “GK01 injection”.

Its studies are mostly in Lung Neoplasms, led by Beijing Geekgene Technology.

Furthest: phase 1, since Mar 16, 20264 company-led studies, 4 open or runningNext primary completion: Dec 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Beijing Geekgene Technology44 open or runningphase 1since Mar 16, 2026Feb 5, 2026Dec 2026phase 1 · NCT07482319

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 5, 2026First studies: 2 early phase 1 studies in Advanced Solid TumorsFirst studyNCT07414316, NCT07412665
  2. Mar 16, 2026Phase 1 study in Advanced Solid TumorsNCT07482319 · 15 planned · China
  3. Jun 23, 2026Early phase 1 study in Advanced Lung CancerNCT07673419 · 10 planned · China

Ahead

  1. Dec 2026Primary completion: phase 1 study in Advanced Solid TumorsNCT07482319
  2. Feb 12, 2027Primary completion: early phase 1 study in Advanced Solid TumorsNCT07414316
  3. Mar 31, 2027Primary completion: early phase 1 study in Advanced Solid TumorsNCT07412665
  4. Jun 2028Primary completion: early phase 1 study in Advanced Lung CancerNCT07673419

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07673419Advanced Lung Cancer · ChinaEarly 1Not yet recruitingJun 202810
NCT07482319Advanced Solid Tumors · China1Not yet recruitingDec 202615
NCT07412665Advanced Solid Tumors · ChinaEarly 1Not yet recruitingMar 31, 202710
NCT07414316Advanced Solid Tumors · ChinaEarly 1RecruitingFeb 12, 202710

How it is read

Names in the registry

  • “GK01 Injection”, 2 entries
  • “GK01 injection”, 2 entries

Codes read as this program: GK01.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.